American Journal of Transplantation· 2012Q1
Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
- 329citations
- Q1SCImago
- 2012year
Short summary
In liver transplant patients, initiating everolimus with reduced tacrolimus (EVR+Reduced TAC) was noninferior to standard tacrolimus (TAC Control) for graft survival and showed superior renal function (8.50 mL/min/1.73 m(2) higher eGFR at 12 months).
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Transplantation
TransplantationMedicine